AbbVie says bar for ‘sham litigation’ is too low
03-06-2021
FTC’s $448m AbbVie win overturned
02-10-2020
AbbVie and Besins to pay FTC $448m in sham litigation case
02-07-2018
Mark Van Scyoc / Shutterstock.com
The US Federal Trade Commission and AbbVie both want a federal appeals court to rehear a lawsuit accusing the drug company of quashing competition through sham patent litigation.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Third Circuit, FTC, AbbVie, Perrigo, Besins, antitrust, sham litigation, patent
